Childhood Cancer

You are here

Home » Grants » All grants tagged with "Neuroblastoma"

All grants tagged with "Neuroblastoma"

GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma
Kristopher Bosse, MD
Children’s Hospital of Philadelphia
Young Investigator Grants, Awarded 2016
Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma
David Debruyne, PhD
Dana-Farber Cancer Institute
Young Investigator Grants, Awarded 2016
The Role of ARID1A in Neuroblastoma Pathogenesis
Hui Shi, PhD
Dana-Farber Cancer Institute
Young Investigator Grants, Awarded 2016
Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation
Eveline Barbieri, MD/PhD
Baylor College of Medicine
Innovation Grants, Awarded 2016
Enhancing Immunotherapy of Neuroblastoma
Alice Yu, MD/PhD, Mitchell Diccianni, PhD
The Regents of the University of California, San Diego
Innovation Grants, Awarded 2016
Development of an anti-KIR3DL1 Antibody to Promote Innate Immunity Against Neuroblastoma
Katherine Hsu, MD/PhD, Nai-Kong Cheung, MD/PhD
Memorial Sloan-Kettering Cancer Center
Innovation Grants, Awarded 2016
Targeted Inhibition of Lin28/let-7 Binding to Treat Pediatric Malignancy
George Daley, MD/PhD
Boston Children’s Hospital
Innovation Grants, Awarded 2016
DFMO Synergy with Chemo-immunotherapy to Eradicate MYC-Driven Neuroblastoma
Michael Hogarty, MD
Children’s Hospital of Philadelphia
Reach Grants, Awarded 2016
Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma
John M. Maris, MD
Children’s Hospital of Philadelphia
Reach Grants, Awarded 2016
An Engineered Nanoimmunotherapy for Treating Neuroblastoma
Rohan Fernandes, PhD
George Washington University
'A' Award Grants, Awarded 2016

Pages

All childhood cancer types

Featured Hero

Destiny Anderson

Destiny had one of the biggest hearts of anyone. Despite everything she'd been through, she was always resilient, brave, and determined in the face of her rare and aggressive brain cancer. Sadly Destiny passed away.
Read more »